Drug utilization of biological drugs in patients over 65 years with Immune- mediated inflammatory diseases through the Italian VALORE network

Study identification

• EU PAS number:
  EUPAS1000000211
• Study ID:
  1000000211
• Official title and acronym:
  Drug utilization of biological drugs in patients over 65 years with Immune- mediated inflammatory diseases through the Italian VALORE network
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study description:
  This study aims to assess the utilization of TNF-alpha inhibitors, anti-interleukin, selective immunosuppressants and anti-integrins in IMIDs patients over 65 years of age to shed a light of their use in clinical practice using data from the VALORE project, specifically observing persistence to biological therapies.
• Study status:
  Planned

Research institutions and networks

Institutions

Pharmacology Unit - Veneto Pharmacovigilance Centre (Pharmacol UNIVR), University Hospital Verona

Italy

Study timelines

Date when funding contract was signed

Planned:01/01/2020

Study start date

Planned:01/02/2024

Data analysis start date

Planned:01/04/2024

Date of final study report

Planned:31/12/0024

Regulatory

• Was the study required by a regulatory body?:
  Unknown
• Is the study required by a Risk Management Plan (RMP)?:
  Non-EU RMP only